{"id":"W3130306790","doi":"10.1158/1538-7445.sabcs20-pd3-08","title":"Abstract PD3-08: Tucatinib vs placebo in combination with trastuzumab and capecitabine for patients with locally advanced unresectable or HER2-positive metastatic breast cancer (HER2CLIMB): Outcomes by hormone receptor status","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Capecitabine; Internal medicine; Metastatic breast cancer; Pertuzumab; Oncology; Trastuzumab; Placebo; Breast cancer; Regimen; Progression-free survival; Neratinib; Cancer; Chemotherapy; Colorectal cancer; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004115341,0.0004294831,0.0008385863,0.0002671833,0.0002341273,0.00008536715,0.0001587517,0.0000996495,0.0006631853],"category_scores_gemma":[0.0001948595,0.0003044548,0.00005034668,0.001100176,0.0004290649,0.0005001904,0.00006902812,0.0006878142,0.000005019747],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001943938,"about_ca_system_score_gemma":0.002202412,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001712191,"about_ca_topic_score_gemma":0.004481012,"domain_scores_codex":[0.9960814,0.000174965,0.0004695838,0.0009083499,0.001163578,0.001202087],"domain_scores_gemma":[0.9962441,0.000805177,0.0001854734,0.0003995404,0.001947186,0.0004185655],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2929264,0.007541795,0.3538521,0.002375686,0.002265801,0.0002083917,0.00555739,0.0007169938,0.03396112,0.0001096591,0.004019525,0.2964652],"study_design_scores_gemma":[0.08700212,0.007051147,0.8787103,0.002384611,0.000170618,0.00003529611,0.005419095,0.00009465665,0.01066627,0.00009133993,0.007496464,0.0008780545],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.984515,0.004218753,0.0004125448,0.004675151,0.00008758037,0.003682079,0.002251237,0.00004863439,0.0001090791],"genre_scores_gemma":[0.9878505,0.001690462,0.003276305,0.0003202745,0.00005481799,0.003949575,0.00058189,0.0001625084,0.00211364],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5248582,"threshold_uncertainty_score":0.9999408,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02296868325512378,"score_gpt":0.3564962812160818,"score_spread":0.333527597960958,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}